Pharmacology of Parkinson?s Disease
Parkinson's Disease (PD) is a progressive and degenerative neurological disorder that affects the control of movement. It results in a gradual impairment of balance, coordination and speech that slowly worsens with time. The pharmacological approach to the treatment of PD involves a combination of drugs that can help to control the symptoms and decrease the progression of the disease. Drugs such as levodopa, dopamine agonists, MAO-B inhibitors, and catechol-O-methyltransferase (COMT) inhibitors are commonly used to directly address the motor symptoms of PD. Anticholinergics, ergolines and selective serotonin reuptake inhibitors (SSRIs) may be used to treat the psychological and cognitive aspects of the illness. Additionally, drugs like anticonvulsants and anti-inflamatories can help lower the chances of developing PD-associated seizures, falls and motor fluctuations. A proper pharmacological treatment plan for PD is essential in helping to reduce the impact of the disease, improve the patient's quality of life and slow its progression.
← Journal of Behavior Therapy And Mental Health